Reflect Scientific, Inc. (RSCF)
USD 0.04
(-3.37%)
USD 0.04
(-3.37%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 596.42 Thousand USD | -104.03% |
| 2022 | 1.21 Million USD | -36.85% |
| 2021 | 1.93 Million USD | 12.16% |
| 2020 | 1.72 Million USD | 73.58% |
| 2019 | 991.64 Thousand USD | -6.87% |
| 2018 | 1.06 Million USD | 61.37% |
| 2017 | 659.84 Thousand USD | -18.79% |
| 2016 | 812.54 Thousand USD | 28.93% |
| 2015 | 630.21 Thousand USD | -25.83% |
| 2014 | 849.63 Thousand USD | 27.0% |
| 2013 | 668.98 Thousand USD | -5.95% |
| 2012 | 711.27 Thousand USD | -28.72% |
| 2011 | 997.89 Thousand USD | -8.43% |
| 2010 | 1.08 Million USD | -50.84% |
| 2009 | 2.21 Million USD | -52.08% |
| 2008 | 4.62 Million USD | 36.58% |
| 2007 | 3.38 Million USD | 221.53% |
| 2006 | 1.05 Million USD | 14.85% |
| 2005 | 917.18 Thousand USD | 11.61% |
| 2004 | 821.81 Thousand USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 210.5 Thousand USD | 261.54% |
| 2024 Q1 | 99.17 Thousand USD | 204.85% |
| 2023 Q3 | 329.98 Thousand USD | 445.13% |
| 2023 FY | -49.09 Thousand USD | -104.03% |
| 2023 Q4 | -94.58 Thousand USD | -128.66% |
| 2023 Q2 | 60.53 Thousand USD | -52.52% |
| 2023 Q1 | 127.49 Thousand USD | -39.01% |
| 2022 Q1 | 349 Thousand USD | -38.37% |
| 2022 FY | 1.21 Million USD | -36.85% |
| 2022 Q2 | 359.79 Thousand USD | 3.09% |
| 2022 Q3 | 131.02 Thousand USD | -63.58% |
| 2022 Q4 | 209.04 Thousand USD | 59.54% |
| 2021 Q4 | 566.28 Thousand USD | 19.52% |
| 2021 Q3 | 473.8 Thousand USD | 0.39% |
| 2021 Q2 | 471.95 Thousand USD | 67.38% |
| 2021 Q1 | 281.96 Thousand USD | -39.98% |
| 2021 FY | 1.93 Million USD | 12.16% |
| 2020 Q3 | 357.97 Thousand USD | -5.89% |
| 2020 Q1 | 513.17 Thousand USD | 62.79% |
| 2020 FY | 1.72 Million USD | 73.58% |
| 2020 Q2 | 380.36 Thousand USD | -25.88% |
| 2020 Q4 | 469.78 Thousand USD | 31.23% |
| 2019 Q2 | 178.93 Thousand USD | -23.01% |
| 2019 Q3 | 265.06 Thousand USD | 48.13% |
| 2019 Q4 | 315.23 Thousand USD | 18.93% |
| 2019 FY | 991.64 Thousand USD | -6.87% |
| 2019 Q1 | 232.4 Thousand USD | -28.78% |
| 2018 FY | 1.06 Million USD | 61.37% |
| 2018 Q4 | 326.32 Thousand USD | 56.91% |
| 2018 Q3 | 207.97 Thousand USD | -2.88% |
| 2018 Q2 | 214.13 Thousand USD | -32.32% |
| 2018 Q1 | 316.37 Thousand USD | 586.3% |
| 2017 Q1 | 165.88 Thousand USD | 34.07% |
| 2017 FY | 659.84 Thousand USD | -18.79% |
| 2017 Q4 | 46.09 Thousand USD | -80.89% |
| 2017 Q3 | 241.23 Thousand USD | 34.61% |
| 2017 Q2 | 179.2 Thousand USD | 8.03% |
| 2016 FY | 812.54 Thousand USD | 28.93% |
| 2016 Q1 | 266.78 Thousand USD | 81.4% |
| 2016 Q4 | 123.73 Thousand USD | -11.51% |
| 2016 Q3 | 139.82 Thousand USD | -50.45% |
| 2016 Q2 | 282.2 Thousand USD | 5.78% |
| 2015 Q1 | 191.9 Thousand USD | -14.74% |
| 2015 FY | 630.21 Thousand USD | -25.83% |
| 2015 Q4 | 147.07 Thousand USD | -1.63% |
| 2015 Q3 | 149.51 Thousand USD | 5.49% |
| 2015 Q2 | 141.72 Thousand USD | -26.15% |
| 2014 Q3 | 174.44 Thousand USD | -17.5% |
| 2014 FY | 849.63 Thousand USD | 27.0% |
| 2014 Q4 | 225.07 Thousand USD | 29.02% |
| 2014 Q2 | 211.44 Thousand USD | -11.4% |
| 2014 Q1 | 238.65 Thousand USD | 46.08% |
| 2013 Q2 | 170.97 Thousand USD | 34.62% |
| 2013 Q4 | 163.37 Thousand USD | -21.31% |
| 2013 Q1 | 127 Thousand USD | -37.94% |
| 2013 Q3 | 207.63 Thousand USD | 21.44% |
| 2013 FY | 668.98 Thousand USD | -5.95% |
| 2012 Q3 | 159.89 Thousand USD | -17.5% |
| 2012 Q4 | 204.65 Thousand USD | 28.0% |
| 2012 FY | 711.27 Thousand USD | -28.72% |
| 2012 Q1 | 152.92 Thousand USD | -28.96% |
| 2012 Q2 | 193.8 Thousand USD | 26.73% |
| 2011 Q2 | 233.79 Thousand USD | -19.88% |
| 2011 Q4 | 215.27 Thousand USD | -16.24% |
| 2011 Q3 | 257.01 Thousand USD | 9.93% |
| 2011 Q1 | 291.8 Thousand USD | 25.51% |
| 2011 FY | 997.89 Thousand USD | -8.43% |
| 2010 Q1 | 270.6 Thousand USD | -56.11% |
| 2010 FY | 1.08 Million USD | -50.84% |
| 2010 Q4 | 232.49 Thousand USD | -20.22% |
| 2010 Q3 | 291.4 Thousand USD | -1.3% |
| 2010 Q2 | 295.24 Thousand USD | 9.11% |
| 2009 Q3 | 213.57 Thousand USD | -71.74% |
| 2009 FY | 2.21 Million USD | -52.08% |
| 2009 Q1 | 630.95 Thousand USD | 67.86% |
| 2009 Q2 | 755.65 Thousand USD | 19.76% |
| 2009 Q4 | 616.59 Thousand USD | 188.7% |
| 2008 Q3 | 1.63 Million USD | 2.59% |
| 2008 Q2 | 1.59 Million USD | 55.07% |
| 2008 Q4 | 375.89 Thousand USD | -76.98% |
| 2008 Q1 | 1.02 Million USD | 30.07% |
| 2008 FY | 4.62 Million USD | 36.58% |
| 2007 Q4 | 789.01 Thousand USD | 78.15% |
| 2007 FY | 3.38 Million USD | 221.53% |
| 2007 Q1 | 411.03 Thousand USD | 27.25% |
| 2007 Q2 | 1.74 Million USD | 324.31% |
| 2007 Q3 | 442.9 Thousand USD | -74.6% |
| 2006 Q3 | 235 Thousand USD | -2.28% |
| 2006 Q1 | 254.91 Thousand USD | 22.11% |
| 2006 Q4 | 323 Thousand USD | 37.44% |
| 2006 FY | 1.05 Million USD | 14.85% |
| 2006 Q2 | 240.48 Thousand USD | -5.66% |
| 2005 Q4 | 208.75 Thousand USD | -15.66% |
| 2005 FY | 917.18 Thousand USD | 11.61% |
| 2005 Q3 | 247.53 Thousand USD | -6.46% |
| 2005 Q1 | 196.28 Thousand USD | 0.0% |
| 2005 Q2 | 264.61 Thousand USD | 34.81% |
| 2004 FY | 821.81 Thousand USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| American Medical Technologies Inc. | 1.69 Million USD | 64.898% |
| Ansell Limited | 624.8 Million USD | 99.905% |
| Ansell Limited | 624.8 Million USD | 99.905% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 113.94 Million USD | 99.477% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | 135.05 Thousand USD | -341.613% |
| Psykey, Inc. | 415.97 Thousand USD | -43.379% |
| ConvaTec Group Plc | 1.2 Billion USD | 99.95% |
| ConvaTec Group Plc | 1.17 Billion USD | 99.949% |
| Encision Inc. | 3.13 Million USD | 80.981% |
| Golden Valley Development, Inc | - USD | -Infinity% |
| Hear AtLast Holdings, Inc. | - USD | -Infinity% |
| Innovative MedTech Inc. | 794.01 Thousand USD | 24.885% |
| LifePoint, Inc. | -71.35 Thousand USD | 935.815% |
| Medite Cancer Diagnostics, Inc. | -131 Thousand USD | 555.283% |
| Paradigm Medical Industries, Inc. | 525 Thousand USD | -13.604% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | 603.24 Thousand USD | 1.13% |
| SmileDirectClub, Inc. | 275.84 Million USD | 99.784% |
| Sector 10, Inc. | - USD | -Infinity% |
| Shandong Weigao Group Medical Polymer Company Limited | 900.72 Million USD | 99.934% |
| SheerVision, Inc. | 2.17 Million USD | 72.59% |
| United Health Products, Inc. | -4857.00 USD | 12379.617% |
| Vasamed, Inc. | -69.38 Thousand USD | 959.545% |
| Wearable Health Solutions, Inc. | 267.66 Thousand USD | -122.825% |
| Yubo International Biotech Limited | 52.65 Thousand USD | -1032.76% |